Search

Your search keyword '"Kim, Dong-Sik"' showing total 6 results
Start Over Author "Kim, Dong-Sik" Journal transplantation
6 results on '"Kim, Dong-Sik"'

1. Comparison of Clinical Outcomes Using Left and Right Liver Grafts in Adult-to-adult Living-donor Liver Transplantation: A Retrospective Cohort Study Using the Korean Organ Transplantation Registry

Author

Jo, Hye-Sung, Kim, Dong-Sik, Cho, Jai Young, Hwang, Shin, Choi, YoungRok, Kim, Jong Man, Lee, Jae Geun, You, Young Kyoung, Choi, Donglak, Ryu, Je Ho, Kim, Bong-Wan, Nah, Yang Won, Ju, Man ki, Kim, Tae-Seok, Suh, Suk-Won, Soo Kim, Myoung, Jin Joo, Dong, Lee, Juhan, Kim, Deok-Gie, Ihn, Kyong, Min, Eun-Ki, Park, Gilchun, Kang, Woo-Hyoung, LEE, Kwang-Woong, Yi, Nam-Joon, Hong, Suk Kyun, Lee, Jeong-Moo, Rhu, Jinsoo, Yang, Kwangho, Choi, Byung Hyun, Hong, Sung Yeon, Yang, Hye yeon, Kim, Joo Dong, Yu, Young Dong, Park, Jeong-Ik, Kang, Koo Jeong, Lee, Hae Won, Hong, Geun, Moon, Ju Ik, choi, In Seok, Yu, Hee Chul, Yang, Jae Do, Kim, kyeong Sik, Jung, Yun Kyung, Jeong, Jaehong, Lee, Okjoo, Woo, Kim Kwan, Kang, Sunghwa, Na Choi, Soo Jin, Kim, Hyo-Sin, Park, PyoungJae, Kim, Wan-Joon, Kim, Bum-Soo, Park, Min-Su, Park, Yeon Ho, Kim, Doojin, Choi, Sang Tae, Choi, Young Il, Shin, Woo Young, and Kim, Kyeong Deok

Published
2025
Full Text
View/download PDF

2. Post Living Donor Liver Transplantation Small-for-size Syndrome: Definitions, Timelines, Biochemical, and Clinical Factors for Diagnosis: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference

Author

Kow, Alfred Wei Chieh, Liu, Jiang, Patel, Madhukar S., De Martin, Eleonora, Reddy, Mettu Srinivas, Soejima, Yuji, Syn, Nicholas, Watt, Kymberly, Xia, Qiang, Saraf, Neeraj, Kamel, Refaat, Nasralla, David, McKenna, Greg, Srinvasan, Parthi, Elsabbagh, Ahmed M., Pamecha, Vinayendra, Palaniappan, Kumar, Mas, Valeria, Tokat, Yaman, Asthana, Sonal, Cherukuru, Ramkiran, Egawa, Hiroto, Lerut, Jan, Broering, Dieter, Berenguer, Marina, Cattral, Mark, Clavien, Pierre-Alain, Chen, Chao-Long, Shah, Samir, Zhu, Zhi-Jun, Emond, Jean, Ascher, Nancy, Rammohan, Ashwin, Bhangui, Prashant, Rela, Mohamed, Kim, Dong-sik, and Ikegami, Toru

Published
2023
Full Text
View/download PDF

3. Physical Performance Decline During the Early Posttransplantation Period Affects Survival After Living Donor Liver Transplantation

Author

Kim, Deok-Gie, Hwang, Shin, Lee, Kwang-Woong, Choi, Gyu-seong, You, Young Kyoung, Ryu, Je Ho, Kim, Bong-Wan, Nah, Yang Won, Kim, Dong-Sik, Cho, Jai Young, Kang, Koo Jeong, Hong, Geun, Yu, Hee Chul, Ju, Man ki, Suh, Suk-Won, Kim, Kwan Woo, Choi, Dongho, Jeong, Jaehong, Choi, Soo Jin Na, Moon, Ju Ik, Lee, Jae Geun, Kim, Myoung soo, Choi, Donglak, and Joo, Dong Jin

Published
2023
Full Text
View/download PDF

6. Clinical Significance of Grade A Small-for-size Syndrome After Living Donor Liver Transplantation Utilizing the New Definition of Diagnostic Criteria: An International Multicenter Study.

Author

Jo HS, Kim DS, Gunasekaran V, Krishnamurthy J, Toshima T, Takahashi R, Kim JY, Krishnan SK, Okumura S, Hara T, Shimata K, Haruki K, Minnee RC, Rammohan A, Gupta S, Yoshizumi T, Ikegami T, Lee KW, and Rela M

Abstract

Background: New diagnostic criteria have recently been established to classify small-for-size syndrome (SFSS) after living donor liver transplantation into 3 groups based on severity. This study aimed to evaluate the clinical impact of grade A SFSS and identify the mortality risk., Methods: We collected data from 406 patients diagnosed with grade A SFSS after living donor liver transplantation. Grade A SFSS is characterized by total bilirubin >5 mg/dL on postoperative day (POD) 7 or total bilirubin >5 mg/dL or ascites >1 L/d on POD 14. After propensity score matching, 193 patients were categorized into the up-trend group, down-trend group, and ascites group, with 43 patients (22.3%) in the up-trend group (total bilirubin on POD 7 < POD 14), 107 patients (55.4%) in the down-trend group (total bilirubin on POD 7 > POD 14), and 43 patients (22.3%) in the ascites group (only satisfying ascites criteria)., Results: There was no significant difference in survival between patients with grade A SFSS and those without SFSS (P = 0.152). The up-trend group showed a higher 90-d mortality rate than the down-trend and ascites groups (P = 0.025). The 1-y survival rate differed significantly between the groups (87.6%, 91.9%, and 97.7%, respectively; P = 0.044). The independent risk factors for survival were up-trend of total bilirubin, recipient age (65 y and older), model for end-stage liver disease score (≥30), and ABO incompatibility. Patients with ≥2 risk factors had worse survival rates than those with none and only 1 risk factor (P < 0.001)., Conclusions: Although the survival rate was comparable between the grade A SFSS and non-SFSS cohorts, the up-trend group showed worse survival. Aggressive interventions should be considered for up-trend patients with risk factors., Competing Interests: The authors declare no conflicts of interest., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results